Philip Morris International Named Among WSJ's 'Best Companies For the Future'

Philip Morris International (PMI) has been recognized by the WSJ Leadership Institute, being named among its inaugural “Best Companies For the Future” ranking. The ranking evaluates large corporations on their ability to adapt and succeed in a rapidly evolving global environment. PMI secured the #97 position overall and was the third highest-ranked company within the Food Beverage & Tobacco industry group, as reported by PMI Investor Relations. This acknowledgment highlights the company's strategic evolution towards a smoke-free future.

The “Best Companies for the Future” ranking, compiled by Bendable Labs for the WSJ Leadership Institute, assesses companies across six key dimensions: AI readiness, innovation, talent readiness, financial fitness, resilience, and agility. The methodology uses 30 indicators from multiple external providers to evaluate S&P 500 companies. PMI's Group CEO, Jacek Olczak, stated that the recognition underscores the company's commitment to reinventing PMI and delivering long-term value, driven by innovation and a strategy to adapt to changing consumer preferences and technologies.

PMI's inclusion reflects its focus on a smoke-free future, supported by investments in science, innovation, and organizational capabilities. The company's smoke-free products, which include heat-not-burn, nicotine pouch, and e-vapor products, are available in over 105 markets. As of December 31, 2025, PMI estimated these products were used by over 43 million legal-age consumers globally. The smoke-free business segment contributed 43% of PMI’s first-quarter 2026 total net revenues. This information was also disseminated via Business Wire and AETOSWire, confirming the widespread announcement of the recognition.

Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products for adults who would otherwise smoke. This investment includes building scientific assessment capabilities in pre-clinical systems toxicology, clinical and behavioral research, and post-market studies. The U.S. Food and Drug Administration (FDA) has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches, as well as versions of PMI’s IQOS devices and consumables, following a science-based review. Versions of IQOS devices and consumables and General snus also obtained Modified Risk Tobacco Product (MRTP) authorizations from the FDA.

PMI's flagship heating tobacco product, IQOS, was also listed among Kantar’s BrandZ 2026 Most Valuable Global Brands, further indicating its market presence for adult nicotine consumers seeking alternatives to cigarettes. The company aims to evolve its portfolio to include products outside of the tobacco and nicotine sector, with a long-term ambition to expand into wellness areas, leveraging its expertise in life sciences.